FTO and lung adenocarcinoma: Consistent results showed that Wnt treatment of H322 and H358 lung adenocarcinoma cells reduced the mRNA (Fig. 2C) and protein (Fig. 2D) levels of FTO. This reduction was abrogated by depletion of β-catenin, which enhanced FTO expression (Fig. 2C, D).